Literature DB >> 24101703

Effect of gestational age on mRNA and protein expression of polyspecific organic cation transporters during pregnancy.

Nora Lee1, Mary F Hebert, Bhagwat Prasad, Thomas R Easterling, Edward J Kelly, Jashvant D Unadkat, Joanne Wang.   

Abstract

Polyspecific organic cation (OC) transporters play important roles in the disposition of clinically used drugs, including drugs used during pregnancy. Pregnancy is known to alter the expression of drug-metabolizing enzymes and transporters, but its specific effect on OC transporters has not been well defined. Using quantitative polymerase chain reaction and liquid chromatography coupled with tandem mass spectrometry targeted proteomics, we determined the effect of pregnancy and gestational age on mRNA and protein expression of major OC transporters in the kidney, liver, and placenta in mice with timed pregnancies. Human organic cation transporter 3 (hOCT3) expression was further investigated in human placentas from the first and second trimesters and at term. Our results showed that pregnancy had a marginal effect on renal mouse organic cation transporter 1/2 (mOct1/2) expression but significantly reduced mouse multidrug and toxin extrusion transporter 1 (mMate1) expression by 20%-40%. Hepatic expression of mOct1 and mMate1 was minimally affected by pregnancy. Human and mouse placentas predominantly expressed OCT3 with little expression of OCT1/2, MATE1/2, and plasma membrane monoamine transporter (PMAT). The hOCT3 protein in first and second trimester and term placentas was quantified to be 0.23 ± 0.033, 0.38 ± 0.072, and 0.36 ± 0.099 fmol/μg membrane protein, respectively. In contrast with the moderate increase in hOCT3 protein during human pregnancy, mOct3 expression in the mouse placenta was highly dependent on gestational age. Compared with gestational day (gd) 10, placental mOct3 mRNA increased by 37-fold and 46-fold at gd 15 and 19, leading to a 56-fold and 128-fold increase in mOct3 protein, respectively. Our study provides new insights into the effect of pregnancy on the expression of polyspecific OC transporters and supports an important role of OCT3 in OC transport at the placental barrier.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24101703      PMCID: PMC3834131          DOI: 10.1124/dmd.113.054072

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  36 in total

1.  A human transporter protein that mediates the final excretion step for toxic organic cations.

Authors:  Masato Otsuka; Takuya Matsumoto; Riyo Morimoto; Shigeo Arioka; Hiroshi Omote; Yoshinori Moriyama
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

2.  P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages.

Authors:  Anita A Mathias; Jane Hitti; Jashvant D Unadkat
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-06-16       Impact factor: 3.619

3.  Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta.

Authors:  R Kekuda; P D Prasad; X Wu; H Wang; Y J Fei; F H Leibach; V Ganapathy
Journal:  J Biol Chem       Date:  1998-06-26       Impact factor: 5.157

4.  Functional analysis of organic cation transporter 3 expressed in human placenta.

Authors:  Ryoko Sata; Hisakazu Ohtani; Masayuki Tsujimoto; Hideyasu Murakami; Noriko Koyabu; Takanori Nakamura; Takeshi Uchiumi; Michihiko Kuwano; Hideaki Nagata; Kiyomi Tsukimori; Hitoo Nakano; Yasufumi Sawada
Journal:  J Pharmacol Exp Ther       Date:  2005-08-04       Impact factor: 4.030

5.  Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1.

Authors:  Naoko Kimura; Satohiro Masuda; Yuko Tanihara; Harumasa Ueo; Masahiro Okuda; Toshiya Katsura; Ken-Ichi Inui
Journal:  Drug Metab Pharmacokinet       Date:  2005-10       Impact factor: 3.614

6.  Interaction of organic cations with a newly identified plasma membrane monoamine transporter.

Authors:  Karen Engel; Joanne Wang
Journal:  Mol Pharmacol       Date:  2005-08-11       Impact factor: 4.436

7.  Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient mice.

Authors:  R Zwart; S Verhaagh; M Buitelaar; C Popp-Snijders; D P Barlow
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

8.  Expression of the breast cancer resistance protein (Bcrp1/Abcg2) in tissues from pregnant mice: effects of pregnancy and correlations with nuclear receptors.

Authors:  Honggang Wang; Xiaohui Wu; Kelly Hudkins; Andrei Mikheev; Huixia Zhang; Anshul Gupta; Jashvant D Unadkat; Qingcheng Mao
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-12       Impact factor: 4.310

9.  Identification and characterization of a novel monoamine transporter in the human brain.

Authors:  Karen Engel; Mingyan Zhou; Joanne Wang
Journal:  J Biol Chem       Date:  2004-09-23       Impact factor: 5.157

10.  Interindividual variability in the hepatic expression of the human breast cancer resistance protein (BCRP/ABCG2): effect of age, sex, and genotype.

Authors:  Bhagwat Prasad; Yurong Lai; Yvonne Lin; Jashvant D Unadkat
Journal:  J Pharm Sci       Date:  2013-01-01       Impact factor: 3.534

View more
  28 in total

1.  Effects of Pregnancy on the Pharmacokinetics of Metformin.

Authors:  Michael Z Liao; Shannon K Flood Nichols; Mahmoud Ahmed; Shannon Clark; Gary D Hankins; Steve Caritis; Raman Venkataramanan; David Haas; Sara K Quinney; Laura S Haneline; Alan T Tita; Tracy Manuck; Joanne Wang; Kenneth E Thummel; Linda Morris Brown; Zhaoxia Ren; Thomas R Easterling; Mary F Hebert
Journal:  Drug Metab Dispos       Date:  2020-01-24       Impact factor: 3.922

Review 2.  Optimized approaches for quantification of drug transporters in tissues and cells by MRM proteomics.

Authors:  Bhagwat Prasad; Jashvant D Unadkat
Journal:  AAPS J       Date:  2014-04-22       Impact factor: 4.009

3.  Role of ABC and Solute Carrier Transporters in the Placental Transport of Lamivudine.

Authors:  Martina Ceckova; Josef Reznicek; Zuzana Ptackova; Lukas Cerveny; Fabian Müller; Marian Kacerovsky; Martin F Fromm; Jocelyn D Glazier; Frantisek Staud
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

4.  Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir.

Authors:  Xiaomei I Liu; Jeremiah D Momper; Natella Rakhmanina; John N van den Anker; Dionna J Green; Gilbert J Burckart; Brookie M Best; Mark Mirochnick; Edmund V Capparelli; André Dallmann
Journal:  J Clin Pharmacol       Date:  2019-09-06       Impact factor: 3.126

5.  Prenatal metformin exposure or organic cation transporter 3 knock-out curbs social interaction preference in male mice.

Authors:  Valentina R Garbarino; Taylor A Santos; Anastassia R Nelson; Wynne Q Zhang; Corey M Smolik; Martin A Javors; Lynette C Daws; Georgianna G Gould
Journal:  Pharmacol Res       Date:  2018-11-10       Impact factor: 7.658

6.  Atenolol Renal Secretion Is Mediated by Human Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Proteins.

Authors:  Jia Yin; Haichuan Duan; Yoshiyuki Shirasaka; Bhagwat Prasad; Joanne Wang
Journal:  Drug Metab Dispos       Date:  2015-09-15       Impact factor: 3.922

7.  Renal secretion of hydrochlorothiazide involves organic anion transporter 1/3, organic cation transporter 2, and multidrug and toxin extrusion protein 2-K.

Authors:  Jia Yin; David J Wagner; Bhagwat Prasad; Nina Isoherranen; Kenneth E Thummel; Joanne Wang
Journal:  Am J Physiol Renal Physiol       Date:  2019-07-19

8.  Serotonin homeostasis in the materno-foetal interface at term: Role of transporters (SERT/SLC6A4 and OCT3/SLC22A3) and monoamine oxidase A (MAO-A) in uptake and degradation of serotonin by human and rat term placenta.

Authors:  Rona Karahoda; Hana Horackova; Petr Kastner; Andreas Matthios; Lukas Cerveny; Radim Kucera; Marian Kacerovsky; Jurjen Duintjer Tebbens; Alexandre Bonnin; Cilia Abad; Frantisek Staud
Journal:  Acta Physiol (Oxf)       Date:  2020-05-18       Impact factor: 6.311

9.  Disposition of Methamphetamine and Major Metabolites in Mice: Role of Organic Cation Transporter 3 in Tissue-Selective Accumulation of Para-Hydroxymethamphetamine.

Authors:  David J Wagner; Laura M Shireman; Sojung Ahn; Danny D Shen; Joanne Wang
Journal:  Drug Metab Dispos       Date:  2018-06-18       Impact factor: 3.922

Review 10.  Placental control of drug delivery.

Authors:  Sanaalarab Al-Enazy; Shariq Ali; Norah Albekairi; Marwa El-Tawil; Erik Rytting
Journal:  Adv Drug Deliv Rev       Date:  2016-08-12       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.